HIV-peplotion vaccine. A novel approach to vaccination against AIDS by transepithelial transport of viral peptides and antigens to Langerhans cells for induction of cytolytic T cells by HLA class I and CD1 molecules for long term protection.
Becker
Y
Y
Department of Molecular Virology, Hebrew University of Jerusalem, Israel.
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control; D018949:Antigens, CD1 / Q000276:immunology*; D000956:Antigens, Viral / Q000276:immunology; D003198:Computer Simulation; D003713:Dendritic Cells / Q000276:immunology; D015195:Drug Design; D004848:Epithelium / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control; D015497:HIV-1 / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014611:Vaccination
D016915:AIDS Vaccines; D018949:Antigens, CD1; D000956:Antigens, Viral; C102830:HIV peplotion vaccine; D015395:Histocompatibility Antigens Class I